You are not logged in so some information on this page has been withheld. To see more, please log in.
Roche
since
auto-detected in 299 stories
13 days ago
Direece Roche, 30, was released in 2023 after serving 12 years of a life sentence imposed in 2011 for stabbing an innocent bystander to death outside a New Year's Day party.
31 days ago
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
41 days ago
Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs
found
a story from The Guardian ⚠ › International
Company says it will create 12,000 jobs in manufacturing and R&D over next five years
- Business live – latest updates
The Swiss drugmaker Roche has said it will put $50bn (£37bn) into manufacturing in t…
42 days ago
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Roche to invest $50 billion in the U.S. as tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Roche to invest $50 billion in the U.S. as tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
75 days ago
Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns
Swiss drugmaker Roche has abandoned global diverse workforce targets, and compatriot Novartis is ending its use of diverse panels for U.S. hiring.